Implementation of DOT statutes 49 U.S.C.  41310(A), 49 U.S.C.  44902(B), 49 U.S.C.  41501, and 49 U.S.C.  41704, regarding cargo transport. Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Verifying Accurate Leading-edge IVCT Development (VALID) Act; Medicare and TRICARE coverage and reimbursement levels for laboratory services and reforms to the Clinical Laboratory Fee Schedule; federal policy relating to drug development; federal policy relating to anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Pub. L. 115-271 (18 U.S.C. 220); and federal policy relating to subject matter eligibility for patents of laboratory tests. FY2020 Defense Appropriations bill, provisions relating to the development of platelet and plasma products for the treatment of traumatic bleeding.
TRA - Transportation HCR - Health Issues DEF - Defense
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS
531 South Spring Street, Burlington, NC, 27215, US
DONALD HORTON KATHERINE PREGEL DONALD HORTON KATHERINE PREGEL DONALD HORTON